Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents
Favourite N Cele, Muthusamy Ramesh, Mahmoud ES Soliman Molecular Modelling and Drug Design Research Group, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa Abstract: A novel virtual screening approach is implemented herein, which is a further improvement of our previously...
Saved in:
Main Authors: | Cele FN (Author), Ramesh M (Author), Soliman ME (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation
by: Shahkaar Aziz, et al.
Published: (2023) -
The Molecular Docking of Specific Reverse Transcriptase Inhibitory Ligands onto the Molecular Model of HIV-1 Reverse Transcriptase
by: Roohallah Yousefi
Published: (2024) -
Pharmacophore modeling and virtual screening for the discovery of new fatty acid amide hydrolase inhibitors
by: Dong-sheng Zhao, et al.
Published: (2011) -
QSAR, pharmacophore modeling and molecular docking studies to identify structural alerts for some nitrogen heterocycles as dual inhibitor of telomerase reverse transcriptase and human telomeric G-quadruplex DNA
by: R. D. Jawarkar, et al.
Published: (2021) -
Approved HIV reverse transcriptase inhibitors in the past decade
by: Guangdi Li, et al.
Published: (2022)